Marc C. Levesque

Rheumatology

2424 Erwin Rd Ste 605
Durham, NC 27705

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

uPAR-Targeting Cytotoxic Antibody-Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune Indications.

uPAR-Targeting Cytotoxic Antibody-Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune Indications.

Journal: Cells

Published: March 04, 2026

Targeting LRRC15 expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases.

Targeting LRRC15 expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases.

Journal: Rheumatology (Oxford, England)

Published: December 31, 2025

Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases.

Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases.

Journal: Rheumatology (Oxford, England)

Published: December 31, 2025

Clonal relationships between Tph and Tfh cells in patients with SLE and in murine lupus.

Clonal relationships between Tph and Tfh cells in patients with SLE and in murine lupus.

Journal: Research square

Published: September 18, 2025

A Novel PTPN2 Isoform Differentially Regulates Immune Response.

A Novel PTPN2 Isoform Differentially Regulates Immune Response.

Journal: European journal of immunology

Published: August 28, 2025

Clonal relationships between Tph and Tfh cells in patients with SLE and in murine lupus.

Clonal relationships between Tph and Tfh cells in patients with SLE and in murine lupus.

Journal: bioRxiv : the preprint server for biology

Published: February 20, 2025

Identification of disease-stage therapeutic responses of mesenchymal stromal cells retrieved from murine osteoarthritic joints.

Identification of disease-stage therapeutic responses of mesenchymal stromal cells retrieved from murine osteoarthritic joints.

Journal: Frontiers in cell and developmental biology

Published: November 01, 2024

IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ.

IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ.

Journal: Frontiers in immunology

Published: September 13, 2023

The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-α Inadequate Response Mechanisms.

The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-α Inadequate Response Mechanisms.

Journal: Inflammatory bowel diseases

Published: June 30, 2022

Epithelial dysfunction is prevented by IL-22 treatment in a Citrobacter rodentium-induced colitis model that shares similarities with inflammatory bowel disease.

Epithelial dysfunction is prevented by IL-22 treatment in a Citrobacter rodentium-induced colitis model that shares similarities with inflammatory bowel disease.

Journal: Mucosal immunology

Published: December 17, 2021

Synovial Inflammatory Pathways Characterize Anti-TNF-Responsive Rheumatoid Arthritis Patients.

Synovial Inflammatory Pathways Characterize Anti-TNF-Responsive Rheumatoid Arthritis Patients.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 27, 2021

Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms.

Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms.

Journal: PloS one

Published: October 01, 2020

Showing 1-12 of 54

Last Updated: 09/26/2026